A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a low ...
MedPage Today on MSN
Off-label drug proves its mettle in relapsing multiple sclerosis
Rituximab and ocrelizumab go head to head in randomized trial ...
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...
The Anne Arundel County resident recently announced his retirement because of complications surrounding a multiple sclerosis ...
A gene variant tied to more severe MS disability may also correlate with poor cognitive performance in healthy adults, per a ...
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...
Changes in the upper spinal cord, measured on routine brain MRI, may help flag higher MS progression risk in people with RRMS ...
Flow Space on MSN
Jamie-Lynn Sigler on Living with Multiple Sclerosis
Sponsored by Novartis Jamie Lynn Sigler opens up about self-advocacy, finding her treatment plan and why your voice should be the loudest in the room when it comes to your health.
Removal of tonsils and adenoids — adenotonsillotomy — is associated with an increased risk of developing and higher activity ...
India, June 28 -- Multiple sclerosis (MS) affects much more than physical health, often disrupting people's social lives, ...
A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results